BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Direct-acting antiviral
1
Analysis of hepatitis C virus positive organs in liver transplantation.
9/23/2022 12:48:56 AM | Browse: 394 | Download: 822
2
Hepatocellular carcinoma, decompensation, and mortality based on hepatitis C treatment: A prospective cohort study
8/10/2022 8:23:14 AM | Browse: 405 | Download: 1318
3
Efficacy and safety of sofosbuvir/velpatasvir with or without ribavirin in hepatitis C genotype 3 compensated cirrhosis: A meta-analysis
6/23/2022 2:39:01 PM | Browse: 453 | Download: 1219
4
Distribution and changes in hepatitis C virus genotype in China from 2010 to 2020
5/13/2022 8:46:13 AM | Browse: 367 | Download: 932
5
Hepatitis C virus failure to treatment: Clinical utility of testing resistance associated substitutions
9/22/2021 8:09:41 AM | Browse: 548 | Download: 1173
6
Safety and efficacy of sofosbuvir/velpatasvir/voxilaprevir in post-liver transplant patients with previous direct-acting antiviral failure: Six case reports
12/18/2020 5:58:43 AM | Browse: 669 | Download: 1262
7
Clinical efficacy of direct-acting antiviral therapy for recurrent hepatitis C virus infection after liver transplantation in patients with hepatocellular carcinoma
9/21/2020 4:02:08 PM | Browse: 627 | Download: 1408
8
Management of hepatitis C in children and adolescents during COVID-19 pandemic
8/25/2020 9:16:00 AM | Browse: 765 | Download: 1420
9
Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients
11/27/2018 1:56:41 PM | Browse: 1062 | Download: 1972
10
Hepatitis C virus infection in children in the era of direct-acting antiviral
6/26/2018 12:26:34 AM | Browse: 1373 | Download: 1538
11
Daclatasvir plus asunaprevir in treatment-naïve patients with hepatitis C virus genotype 1b infection
3/26/2018 8:48:04 AM | Browse: 1315 | Download: 2646
12
Symbiotic chemo- and immuno-therapy for hepatitis B and C viruses
7/4/2016 2:42:00 PM | Browse: 1143 | Download: 1296
13
Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1
3/23/2016 4:26:00 PM | Browse: 1410 | Download: 2295
14
Factors associated with the response to interferon-based antiviral therapies for chronic hepatitis C
11/18/2015 11:12:00 AM | Browse: 1147 | Download: 1916
15
Immune and non-immune responses to hepatitis C virus infection
10/14/2015 12:06:00 PM | Browse: 1155 | Download: 1712
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345